• Kyodo

  • SHARE

Pharmaceutical companies are preparing to secure supplies of influenza drugs as more people in China contract bird flu.

The World Health Organization sees antiviral drugs such as Tamiflu, Inavir and Relenza as effective in containing the H7N9 strain that is reported in China if administered early enough.

Unable to view this article?

This could be due to a conflict with your ad-blocking or security software.

Please add japantimes.co.jp and piano.io to your list of allowed sites.

If this does not resolve the issue or you are unable to add the domains to your allowlist, please see out this support page.

We humbly apologize for the inconvenience.

In a time of both misinformation and too much information, quality journalism is more crucial than ever.
By subscribing, you can help us get the story right.

SUBSCRIBE NOW